The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-09
DOI
10.3389/fpsyt.2021.780921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner
- (2021) Karl Josef Föhr et al. Frontiers in Pharmacology
- Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder
- (2021) Chi-Shin Wu et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder
- (2021) Atsunori Sugimoto et al. MEDICINE
- Evidence-based pharmacological treatment options for ADHD in children and adolescents
- (2021) Konstantin Mechler et al. PHARMACOLOGY & THERAPEUTICS
- Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder
- (2021) Santosh K. Yadav et al. Translational Psychiatry
- Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review
- (2021) Noa Tsujii et al. Neurology and Therapy
- Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis
- (2021) Pei-Yin Pan et al. PSYCHOLOGICAL MEDICINE
- Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research
- (2020) Nada A. Elsayed et al. CNS DRUGS
- Sleep habits of children diagnosed with attention/ deficit/ hyperactivity disorder and effects of treatment on sleep related parameters
- (2020) Çiğdem Yektaş et al. Asian Journal of Psychiatry
- Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine
- (2020) Kevin R. MacKenzie et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Practitioner Review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta‐analysis
- (2020) Rebecca Rodrigues et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
- (2020) Samuele Cortese NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review: Medication Effects on Brain Intrinsic Functional Connectivity in Patients With Attention-Deficit/Hyperactivity Disorder
- (2020) Victor Pereira-Sanchez et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis
- (2019) Suravi Patra et al. Autism Research
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy
- (2019) Jacob T. Brown et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents
- (2019) Olivia S Kowalczyk et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys
- (2019) Patrick M. Callahan et al. NEUROPHARMACOLOGY
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
- (2019) Mark L. Wolraich et al. PEDIATRICS
- A comparison of efficacy between cognitive behavioral therapy (CBT) and CBT combined with medication in adults with attention-deficit/hyperactivity disorder (ADHD)
- (2019) Mei-Rong Pan et al. PSYCHIATRY RESEARCH
- Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial
- (2019) Emma Sciberras et al. BMC Psychiatry
- Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
- (2019) Richard Houghton et al. CNS DRUGS
- Comparative Efficacy of Methylphenidate and Atomoxetine on Social Adjustment in Youths with Attention-Deficit/Hyperactivity Disorder
- (2019) Chi-Yung Shang et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Prevalence of ADHD and Its Comorbidities in a Population-Based Sample
- (2019) Mohammad-Reza Mohammadi et al. Journal of Attention Disorders
- Atomoxetine Reestablishes Long Term Potentiation in a Mouse Model of Attention Deficit/Hyperactivity Disorder
- (2019) Ricardo Piña et al. NEUROSCIENCE
- Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder
- (2018) Morgan Walls et al. Academic Pediatrics
- Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis
- (2018) Sarah C. O. S. Padilha et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial
- (2018) Kristi R. Griffiths et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cognitive-Behavioral Therapy for Children With Anxiety and Comorbid Attention-Deficit/Hyperactivity Disorder
- (2018) Karen L. Gould et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Comparative Efficacy of Methylphenidate and Atomoxetine on Emotional and Behavioral Problems in Youths with Attention-Deficit/Hyperactivity Disorder
- (2018) Hsien-Hsueh Shih et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial
- (2017) Sally Shaywitz et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Factors that Affect the Adherence to ADHD Medications during a Treatment Continuation Period in Children and Adolescents: A Nationwide Retrospective Cohort Study Using Korean Health Insurance Data from 2007 to 2011
- (2017) Soo-Young Bhang et al. Psychiatry Investigation
- Differential long-term medication impact on executive function and delay aversion in ADHD
- (2017) Belen Rubio Morell et al. Applied Neuropsychology-Child
- Pharmacokinetic Profile and Palatability of Atomoxetine Oral Solution in Healthy Japanese Male Adults
- (2016) Masako Nakano et al. CLINICAL DRUG INVESTIGATION
- Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD
- (2016) JT Brown et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research
- (2016) Victoria A. Reed et al. CNS DRUGS
- Psychiatric Comorbidity and Demographic Characteristics of 1,000 Children and Adolescents With ADHD in Turkey
- (2016) Sevim Berrin Inci et al. Journal of Attention Disorders
- Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition
- (2016) Guo Yu et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up
- (2016) Yi Su et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder
- (2016) C. Y. Shang et al. PSYCHOLOGICAL MEDICINE
- Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5
- (2016) Rebecca Grzadzinski et al. Molecular Autism
- The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research
- (2015) Nicola C. Savill et al. CNS DRUGS
- Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
- (2015) Paul G Hammerness et al. Expert Opinion On Drug Safety
- Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial
- (2015) Hsiang-Yuan Lin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder
- (2015) Himanshu Upadhyaya et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder
- (2015) Bedia Ince Tasdelen et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder
- (2015) Chi-Yung Shang et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients
- (2015) David B Clemow et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A critical appraisal of atomoxetine in the management of ADHD
- (2015) Ann Childress Therapeutics and Clinical Risk Management
- Reading Outcomes of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia Following Atomoxetine Treatment
- (2014) Bennett A. Shaywitz et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Reduced Short Interval Cortical Inhibition Correlates With Atomoxetine Response in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
- (2014) Tina H Chen et al. JOURNAL OF CHILD NEUROLOGY
- Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: An integrated analysis of 15 clinical trials
- (2014) Angelo Camporeale et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
- (2014) Blanca Bolea-Alamañac et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Attention Deficit–Hyperactivity Disorder in Children and Adolescents
- (2014) Heidi M. Feldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study
- (2014) Q. Chen et al. BMJ-British Medical Journal
- Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
- (2013) Ralf W. Dittmann et al. CNS DRUGS
- Life-threatening QT prolongation in a boy with attention-deficit/hyperactivity disorder on atomoxetine
- (2013) Hiroshi Yamaguchi et al. EUROPEAN JOURNAL OF PEDIATRICS
- A Meta-analysis of the Consistency of Atomoxetine Treatment Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder from 15 Clinical Trials Across Four Geographic Regions
- (2013) Yoko Tanaka et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Fast vs. Slow Switching from Stimulants to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
- (2013) Esther Cardo et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents
- (2013) Samuele Cortese et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Atomoxetine Tolerability in Pediatric and Adult Patients Receiving Different Dosing Strategies
- (2013) Linda A. Wietecha et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression
- (2013) Shimon Schwartz et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD
- (2013) Y.-S. Ding et al. NEUROIMAGE
- Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
- (2013) Wilfried Pott et al. Obesity Facts
- Atomoxetine for Treating ADHD Symptoms in Autism
- (2012) Ahmad Ghanizadeh Journal of Attention Disorders
- Cardiovascular Measures in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Who Are New Users of Methylphenidate and Atomoxetine
- (2012) Romano Arcieri et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Safety of Attention-Deficit/Hyperactivity Disorder Medications in Children: An Intensive Pharmacosurveillance Monitoring Study
- (2012) Simona Ruggiero et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Neurobiological Circuits Regulating Attention, Cognitive Control, Motivation, and Emotion: Disruptions in Neurodevelopmental Psychiatric Disorders
- (2012) Amy F.T. Arnsten et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder
- (2012) Myriam Harfterkamp et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Disorder-specific functional abnormalities during sustained attention in youth with Attention Deficit Hyperactivity Disorder (ADHD) and with Autism
- (2012) A Christakou et al. MOLECULAR PSYCHIATRY
- ADHD Treatments, Sleep, and Sleep Problems: Complex Associations
- (2012) Mark A. Stein et al. Neurotherapeutics
- Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder
- (2012) Heledd Hart et al. JAMA Psychiatry
- The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder
- (2011) Natalia del Campo et al. BIOLOGICAL PSYCHIATRY
- Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
- (2011) Amy F.T. Arnsten BIOLOGICAL PSYCHIATRY
- Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
- (2011) Raveen Hanwella et al. BMC Psychiatry
- Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder
- (2011) Yu-Shu Huang et al. CNS DRUGS
- ADHD medication use, adherence, persistence and cost among Texas Medicaid children
- (2011) Jamie C. Barner et al. CURRENT MEDICAL RESEARCH AND OPINION
- Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany
- (2011) Ralf W. Dittmann et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD
- (2011) C. J. Kratochvil et al. PEDIATRICS
- Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder
- (2010) Kate Langley et al. BRITISH JOURNAL OF PSYCHIATRY
- An ‘integrative neuroscience’ perspective on ADHD: linking cognition, emotion, brain and genetic measures with implications for clinical support
- (2010) Leanne M Williams et al. Expert Review of Neurotherapeutics
- Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice
- (2010) Ken Koda et al. JOURNAL OF NEUROCHEMISTRY
- Global and local fMRI signals driven by neurons defined optogenetically by type and wiring
- (2010) Jin Hyung Lee et al. NATURE
- Once-Daily Atomoxetine for Treating Pediatric Attention-Deficit/Hyperactivity Disorder: Comparison of Morning and Evening Dosing
- (2009) Stan L. Block et al. CLINICAL PEDIATRICS
- Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions
- (2009) Grazia DellʼAgnello et al. CNS DRUGS
- Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
- (2009) Sharon B. Wigal CNS DRUGS
- Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment
- (2009) Suzanne McCarthy et al. DRUG SAFETY
- Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
- (2009) Ferenc Martenyi et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine
- (2009) Susan Shur-Fen Gau et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Predictive Factors for Persistent Use and Compliance of Immediate-Release Methylphenidate: A 36-Month Naturalistic Study
- (2009) Paola Atzori et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Safety and Tolerability of Atomoxetine Over 3 to 4 Years in Children and Adolescents With ADHD
- (2009) Craig Donnelly et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Atomoxetine
- (2009) Karly P. Garnock-Jones et al. PEDIATRIC DRUGS
- Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response
- (2008) Jeffrey H. Newcorn et al. AMERICAN JOURNAL OF PSYCHIATRY
- Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study
- (2008) Samuel R. Chamberlain et al. BIOLOGICAL PSYCHIATRY
- Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder
- (2008) Mark E Bangs et al. DRUG SAFETY
- Latino Versus Caucasian Response to Atomoxetine in Attention-Deficit/Hyperactivity Disorder
- (2008) Jorge M. Tamayo et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder
- (2008) M. E. Bangs et al. PEDIATRICS
- Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy
- (2008) Christopher J Kratochvil et al. Child and Adolescent Psychiatry and Mental Health
- Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome
- (2007) Thomas J. Spencer et al. Journal of Attention Disorders
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started